Study: PBMs setting wildly variable prescription prices for patients at the counter, per APCI
Additionally, the study reveals wild swings in prescription pricing set by PBMs and charged to patients.
- Additionally, the study reveals wild swings in prescription pricing set by PBMs and charged to patients.
- The study was performed by data analytics firm 3 Axis Advisors and was sponsored by American Pharmacy Cooperative, Inc. (APCI).
- The study is replete with examples of variability and the arbitrariness of PBM-set drug prices.
- Simply put, the system is broken, and PBMs can no longer be trusted to set drug prices."